# Defibrotide Dose-escalation for SOS Post-HSCT

> **NCT05987124** · PHASE2 · RECRUITING · sponsor: **New York Medical College** · enrollment: 20 (estimated)

## Conditions studied

- Sinusoidal Obstruction Syndrome
- Veno-occlusive Disease

## Interventions

- **DRUG:** Defibrotide

## Key facts

- **NCT ID:** NCT05987124
- **Lead sponsor:** New York Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-20
- **Primary completion:** 2027-08-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05987124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05987124, "Defibrotide Dose-escalation for SOS Post-HSCT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05987124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*